Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine Round Up 2025 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    Lavni Ventures Marks First Close of Early Stage Deep Tech Impact Fund

    Lavni Ventures Marks First Close of Early-Stage Deep-Tech Impact Fund


    Finance Outlook India Team | Monday, 11 August 2025

    Lavni Ventures has launched a deep-tech impact fund worth Rs 200 crore to support India's most promising science-led startups, bringing global scale to climate, healthcare, energy, and education breakthroughs.

    With government-backed policies such as the National Deep Tech Startup Policy and the Deep Tech Innovation Platform gaining traction, Lavni Fund II intends to capitalize on this momentum by investing in technology-driven solutions that can profitably address some of the world's most challenging problems.

    Key Highlights

    • Lavni Ventures completes ₹200 crore first close of Fund II to back deep-tech startups in climate, healthcare, energy, education.
    • Fund II targets Seed to Series A stages, deploying ₹2–15 crore per startup with proven impact potential.

    Padcare Labs, Monitra Healthcare, and MedPrime Technologies are among Lavni's portfolio companies, demonstrating the potential of India's deep-tech ecosystem. Fund I startups have saved over 3.5 million student learning hours, 10,000 healthcare interventions in underserved markets, and 303 metric tons of CO₂ equivalent as of FY25.

    "The successful launch of Fund II, with strong repeat participation from Fund I LPs, validates our core hypothesis: Indian deep-tech founders are uniquely positioned to deliver scalable impact and attractive returns," said Vasu Guruswamy, co-founder and General Partner at Lavni Ventures.

    According to Lavni Ventures, Fund II will invest Rs 2 crore to Rs 8 crore per opportunity from Seed to Series A, and Rs 8 crore to Rs 15 crore in follow-on investments. Every year, the fund evaluates over 800 deep-tech deals using a selection process that prioritizes long-term business models, measurable impact, and exit opportunities.

    Also Read: Satin Creditcare Network Ltd. to Launch Women-Led AIF Fund 

    Lavni Ventures, founded in 2020 and led by Vasu Guruswamy, Sanjay Kanvinde, and Krishna Shivram, is a SEBI-registered Category II Alternative Investment Fund. It focuses on deep-tech impact investing, funding early-stage startups in medtech, edtech, cleantech, and agritech sectors.



    Read More:

    Budget 2026 May Bring More Income Tax Relief for Salaried Class

    Truva Raises $9M in Fresh Capital to Scale its Full-stack Resale Homes

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe About Us